This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Strategies for larger families focus on prioritization and flexible allocations. Learn how to tailor a zero-based plan to multiple dependents.
27,842 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
As earnings season arrives, smart investors are drilling into Transcat's 2026 earnings outlook. This guide breaks dow...
Bitunix unveils a Visa-powered debit card allowing users to spend crypto worldwide and earn yields. The card integrat...
Elon Musk announced a Texas-based Terafab chip initiative, a joint venture between TESLA and SPACE X, to build advanc...
NVIDIA CEO Jensen Huang has framed a $40 trillion TAM for labor automation via robotics, prompting a broader look at ...
Investors are weighing UnitedHealth Group after the latest earnings. This guide breaks down what to watch, how to val...
A $20 million unrestricted gift to Santa Barbara City College from Mackenzie Scott is under investigation after the b...
asml stock popped today as investors chased AI-driven demand for semiconductor equipment. This guide breaks down what...
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
Alibaba's KIMI AI model released 2026 price trajectories for XRP, SHIB, and PEPE, highlighting potential upside under...
A single stock in the AI conversation may be quietly delivering outsized, long-term gains. Learn why this Magnificent...